CYTX appears to have several forward looking events occurring in May if this poster on the yahoo board is accurate.
>>
Re: CYTX and GE 16-Apr-10 10:42 pm
Reading between the lines: GE is a big company and was pretty slow to come up to speed. All public indications are GE wants to be a player in regenerative medicine and will no doubt want to keep the relationship. Cytori will probably agree to extend it (more feet on the street) unless there is some unusual event such as a more aggressive distributor or an unexpected buyer or corporate partner that for some reason wants to take over all distribution. That looks unlikely at this point so the relationship will likely stay intact. It is even possible that Cytori might get some consideration from GE for extending the agreement (as suggested by others) but that is generally not the case for simple sales and distribution agreements.
There are several more important and immediate events (coming up before July) to focus on: A. Cardiac Results, Apollo and Precise (early May), B. Improved Q1 financial results (early to mid May), C. Breast reconstruction trial update, Restore II (late May), D. Possible major financial press tied to cardiac or breast results (May), E. Urinary Incontinence study in SF (late May, early June), F. Potential Strategic partnership announcement (Q2 or Q3), G. Probable new research coverage (Q2 or Q3). It should be a very interesting period - wouldn't want to be short! <<<<
